Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

40.11
-1.3350-3.22%
Volume:3.25M
Turnover:130.30M
Market Cap:6.73B
PE:103.31
High:41.26
Open:41.10
Low:39.11
Close:41.45
52wk High:55.67
52wk Low:27.00
Shares:167.76M
Float Shares:155.00M
Volume Ratio:1.41
T/O Rate:2.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3882
EPS(LYR):1.43
ROE:3.85%
ROA:4.20%
PB:3.72
PE(LYR):28.05

Loading ...

Alkermes Plc : TD Cowen Raises Target Price to $58 from $57

THOMSON REUTERS
·
Jul 29

Alkermes Plc : Baird Raises Target Price to $58 from $48

THOMSON REUTERS
·
Jul 29

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 29

Alkermes Price Target Raised to $65.00/Share from $43.00 by Piper Sandler

Dow Jones
·
Jul 29

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Universal Health (UHS)

TIPRANKS
·
Jul 28

Alkermes Plc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 28

Alkermes Releases Transcript of Q2 2026 Earnings Call

Reuters
·
Jul 28

Stock Track | Alkermes Plunges 5.18% in Pre-market After Q2 Earnings Show Sharp Profit Decline

Stock Track
·
Jul 28

Alkermes sinks 5% to $50.05 following Q2 report

TIPRANKS
·
Jul 28

Alkermes Q2 Earnings Flat, Revenue Rises; Reiterates 2026 Revenue Guidance

MT Newswires Live
·
Jul 28

Earnings Flash (ALKS) Alkermes Posts Q2 Revenue $496M, vs. FactSet Est of $457.4M

MT Newswires Live
·
Jul 28

Alkermes Q2 Sales $496.009M Beat $457.818M Estimate

Benzinga Earnings
·
Jul 28

Press Release: Alkermes Plc Reports Second Quarter 2026 Financial Results

Dow Jones
·
Jul 28

Alkermes Plc : Piper Sandler Raises Target Price to $65 from $43

THOMSON REUTERS
·
Jul 28

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 27

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)

TIPRANKS
·
Jul 25

Does Sustained Alixorexton Data in Narcolepsy Reshape The Bull Case For Alkermes (ALKS)?

Simply Wall St.
·
Jul 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 24

Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34

THOMSON REUTERS
·
Jul 21

Earning Preview: Alkermes PLC Q2 revenue expected to increase by 33.98%, institutions tilt positive on near-term revenue resilience

Earnings Agent
·
Jul 21